Vantage Oncology begins change-of-control bid for 9½% notes, sets call

By Angela McDaniels

Tacoma, Wash., April 1 – Vantage Oncology, LLC and Vantage Oncology Finance Co. have begun a change-of-control offer for their 9½% senior secured notes due 2017, according to a company news release.

Parent company Vantage Oncology Holdings, LLC was acquired by McKesson Corp. on April 1.

The issuers are offering 101% of par plus accrued interest up to but excluding the purchase date, which is expected to be May 5.

The offer ends at 5 p.m. ET on May 2.

The issuers will redeem any notes not tendered in the offer at par on June 15.

The depositary for the offer is Wells Fargo Bank, NA (800 344-5128).

Manhattan Beach, Calif. -based Vantage Oncology provides radiation oncology, medical oncology and other cancer care services. McKesson is a San Francisco-based health-care services and information technology company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.